# Clairity

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/clairity

- Industry: Healthcare IT
- Headquarters: Boston, US
- Website: www.clairity.com
- Total disclosed funding: $57M
- Latest round: Series B (Nov 13, 2025)
- Investors on record: 3

## About

Founded in 2020 by founder Connie Lehman and based in Massachusetts, US, Clairity, Inc. operates as a healthcare company that provides a mammography-based deep learning platform. In the domain of radiomics, advancements in AI unlock new insights from the data embedded in the image, the organization accurately identifies those individuals who have the highest risk of developing cancer. Jeffrey R. Luber is the CEO of the company. In November 2025, Clairity, Inc. raised USD 43 million in series B funding co-led by investor ACE & Company and investor Sante Ventures, with participation from another investor Breast Cancer Research Foundation. 

The company provides a mammography-based deep learning platform that is revolutionizing the screening process by improving accuracy, eliminating bias, cultivating trust, reducing the cost of care, and saving lives. The firm's artificial intelligence (AI) and deep learning neural networks offer further advancing the mammography screening process. Clairity’s scientific approach to breast health improves the accuracy of the risk assessment process, allowing clinicians to fulfill the precision medicine and tailor a healthcare experience that is unique to each patient.

 The company will use the November 2025 funding to accelerate U.S. commercialization, expand imaging center partnerships, support reimbursement initiatives, and advance development of Clairity Breast 3D and Clairity Heart for predictive cardiovascular risk assessment.

## Funding rounds

- Series B, Nov 13, 2025, $43M — Sante Ventures, ACE & Company, Breast Cancer Research Foundation
- Series B, Sep 30, 2022, $6.7M — Sante Ventures
- Series A, Nov 4, 2020, $7.5M — Sante Ventures

## Investors

- Sante Ventures (https://capitalatlas.ai/funds/sante-ventures) — Series A, Series B
- ACE & Company (https://capitalatlas.ai/funds/ace-company) — Series B
- Breast Cancer Research Foundation — Series B